Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population

References

• Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467–77.
   PubMedGoogle Scholar
• Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D'Elios MM, Amedei A, Azzurri A, The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol 2005;24:63–91.
   PubMed Web of Science ®Google Scholar
• Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000;165:1022–9.
   PubMed Web of Science ®Google Scholar
• Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004;157:301–10.
   PubMedGoogle Scholar
• Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659–72.
   PubMed Web of Science ®Google Scholar
• Hold G, Rabkin C, Chow W-H, Smith M, Gammon M, Risch H, A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007;132:905–12.
   PubMed Web of Science ®Google Scholar
• Mahajan R, El-Omar E, Lissowska J, Grillo P, Rabkin C, Baccarelli A, Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol 2008;38:626–33.
   PubMedGoogle Scholar
• El-Omar E, Rabkin C, Gammon M, Vaughan T, Risch H, Schoenberg J, Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193–201.
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398–402.
   PubMed Web of Science ®Google Scholar
• Wu M-S, Wu C-Y, Chen C-J, Lin M-T, Shun C-T, Lin J-T. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617–23.
   PubMed Web of Science ®Google Scholar
• Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005;54:330–35.
   PubMed Web of Science ®Google Scholar
• Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007;28:118–23.
   PubMed Web of Science ®Google Scholar
• Machado JC, Figueiredo CU, Canedo P, Pharoah P, Carvalho R, Nabais Sr, A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364–71.
   PubMed Web of Science ®Google Scholar
• Savage S, Abnet C, Mark S, Qiao Y-L, Dong Z-W, Dawsey S, Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:2251–7.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436–44.
   PubMed Web of Science ®Google Scholar
• Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007;256:137–65.
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–86.
   PubMed Web of Science ®Google Scholar
• Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis. J Gastroenterol Hepatol 2006;21:32–40.
   PubMedGoogle Scholar
• Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007;98:1652–8.
   PubMed Web of Science ®Google Scholar
• Ishigami S, Natsugoe S, Okumura H, Matsumoto M, Nakajo A, Uenosono Y, Clinical Implication of CXCL12 Expression in Gastric Cancer. Ann Surg Oncol 2007;14:3154–8.
   PubMedGoogle Scholar
• Woo IS, Hong SH, Byun JH, Kang J-H, Jeon H-M, Choi MG. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma. Cancer Invest 2008;26:256–61.
   PubMed Web of Science ®Google Scholar
• Zieker D, Konigsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem 2008;21:429–36.
   Google Scholar
• Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, Nasierowska-Guttmejer A, Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer 1999;81:871–76.
   PubMedGoogle Scholar
• Lissowska J, Groves FD, Sobin LH, Fraumeni JF, Nasierowska-Guttmejer A, Radziszewski J, Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev 1999;8:223–27.
   PubMedGoogle Scholar
• Wright M, Andreotti G, Lissowska J, Yeager M, Zatonski W, Chanock S, Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer 2009;45:1824–30.
   PubMed Web of Science ®Google Scholar
• Navratilova Z. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacký Olomouc Czech Repub 2006;150:191–204.
   PubMedGoogle Scholar
• Sugasawa H, Ichikura T, Tsujimoto H, Kinoshita M, Morita D, Ono S, Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol 2008;97:445–50.
   PubMed Web of Science ®Google Scholar
• Brand S, Sakaguchi T, Gu X, Colgan S, Reinecker H-C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 2002;122:166–77.
   PubMed Web of Science ®Google Scholar
• Futagami S, Tatsuguchi A, Hiratsuka T, Shindo T, Horie A, Hamamoto T, Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer. J Gastroenterol 2008;43:216–24.
   PubMedGoogle Scholar
• Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588–90.
   PubMed Web of Science ®Google Scholar
• Balistreri CR, Caruso C, Grimaldi MP, Listà F, Vasto S, Orlando V, CCR5 receptor: biologic and genetic implications in age-related diseases. Ann NY Acad Sci 2007;1100:162–72.
   PubMedGoogle Scholar
• Coelho A, Matos A, Catarino R, Pinto D, Pereira D, Lopes C, Medeiros R. Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. Gynecol Oncol 2005;96:760–64.
   PubMed Web of Science ®Google Scholar
• Coelho A, Matos A, Catarino R, Pinto D, Sousa H, Pereira D, Medeiros R. The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol Obstet Invest 2007;64:208–12.
   PubMedGoogle Scholar
• Zafiropoulos A, Crikas N, Passam AM, Spandidos DA. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 2004;41:e59.
   Google Scholar
• Packer B, Yeager M, Burdett L, Welch R, Beerman M, Qi L, SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617–21.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263–5.
   PubMed Web of Science ®Google Scholar
• Schaid D. Evaluating associations of haplotypes with traits. Genet Epidemiol 2004;27:348–64.
   PubMed Web of Science ®Google Scholar
• Schaid D. Linkage disequilibrium testing when linkage phase is unknown. Genetics 2004;166:505–12.
   PubMedGoogle Scholar
• Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, Engel LS, Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001;11:655–61.
   PubMedGoogle Scholar
• Apostolakis S, Amanatidou V, Papadakis E, Spandidos D. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis. Atherosclerosis 2009;207:8–15.
   PubMed Web of Science ®Google Scholar
• Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 2009;47:412–18.
   PubMed Web of Science ®Google Scholar
• Parczewski M, Leszczyszyn-Pynka M, Kaczmarczyk M, Adler G, Binczak-Kuleta A, Loniewska B, Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection. J Appl Genet 2009;50:159–66.
   PubMedGoogle Scholar
• Reiche EM, Bonametti AM, Voltarelli JC, Morimoto HK, Watanabe MA. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Curr Med Chem 2007;14:1325–34.
   PubMedGoogle Scholar
• Wang G, Yu D, Tan W, Zhao D, Wu C, Lin D. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma. Cancer 2009;115:2430–37.
   PubMedGoogle Scholar
• Liou J-M, Lin J-T, Huang S-P, Wu C-Y, Wang H-P, Lee Y-C, RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol 2008;43:115–23.
   PubMed Web of Science ®Google Scholar
• Krauss-Etschmann S, Sammler E, Koletzko S, Konstantopoulos N, Aust D, Gebert B, Chemokine receptor 5 expression in gastric mucosa of Helicobacter pylori-infected and noninfected children. Clin Diagn Lab Immunol 2003;10:22–9.
   PubMedGoogle Scholar
• Conti I, Rollins B. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004;14:149–54.
   PubMed Web of Science ®Google Scholar
• Nakayama E, Tanaka Y, Nagai Y, Iwamoto A, Shioda T. A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 2004;18:729–38.
   PubMedGoogle Scholar
• Sanders SK, Crean SM, Boxer PA, Kellner D, LaRosa GJ, Hunt SW. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 2000;165:4877–83.
   PubMedGoogle Scholar
• Giuntoli RN, Webb T, Zoso A, Rogers O, Diaz-Montes T, Bristow R, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res 2009;29:2875–84.
   PubMed Web of Science ®Google Scholar
• Negus R, Stamp G, Relf M, Burke F, Malik S, Bernasconi S, The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995;95:2391–6.
   PubMed Web of Science ®Google Scholar
• Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003;22:773–8.
   PubMedGoogle Scholar